Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Clinical Investigation

• Publication date

  2011-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1172/JCI57158PMID 21881215PMCID PMC3163962
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer.

  2011cited by this paper
• In vivo effects of the anti-interleukin-6 receptor inhibitor tocilizumab on the B cell compartment.

  2011cited by this paper
• Selective blockade of interleukin-6 trans-signaling improves survival in a murine polymicrobial sepsis model*

  2011cited by this paper
• ADAM17: a molecular switch to control inflammation and tissue regeneration.

  2011cited by this paper
• Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+CD11b(high)Gr1(low) macrophages.

  2011cited by this paper
• Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci

  2010cited by this paper
• Differences in Wound Healing in Mice with Deficiency of IL-6 versus IL-6 Receptor

  2010cited by this paper
• Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action.

  2010cited by this paper
• Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer.

  2010cited by this paper
• A role for IL-27p28 as an antagonist of gp130-mediated signaling

  2010cited by this paper
• Although IL-6 Trans-Signaling Is Sufficient To Drive Local Immune Responses, Classical IL-6 Signaling Is Obligate for the Induction of T Cell-Mediated Autoimmunity

  2010cited by this paper
• Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling.

  2010cited by this paper
• Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance

  2010cited by this paper
• Loss of CD4+ T Cell IL-6R Expression during Inflammation Underlines a Role for IL-6 Trans Signaling in the Local Maintenance of Th17 Cells

  2010influential reference
• IL-6: from its discovery to clinical applications.

  2010influential reference
• Averting inflammation by targeting the cytokine environment

  2010influential reference
• RADIATE: more treatment options for patients with an inadequate response to tumor necrosis factor antagonists

  2009cited by this paper
• Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells.

  2009cited by this paper
• Oncostatin M deficiency leads to thymic hypoplasia, accumulation of apoptotic thymocytes and glomerulonephritis

  2009cited by this paper
• STAT3 expression in gastric cancer indicates a poor prognosis

  2009cited by this paper
• The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo.

  2009cited by this paper
• Essential Roles of IL-6 Trans-Signaling in Colonic Epithelial Cells, Induced by the IL-6/Soluble–IL-6 Receptor Derived from Lamina Propria Macrophages, on the Development of Colitis-Associated Premalignant Cancer in a Murine Model

  2009cited by this paper
• Stat3 downstream genes serve as biomarkers in human lung carcinomas and chronic obstructive pulmonary disease.

  2009cited by this paper
• Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours

  2009cited by this paper
• gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis.

  2009cited by this paper
• IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

  2009cited by this paper
• Therapeutic Targeting of IL-6 Trans Signaling Counteracts STAT3 Control of Experimental Inflammatory Arthritis1

  2009cited by this paper
• STAT3 as a prognostic marker in human gastric cancer

  2009cited by this paper
• gp130 signaling in bone cell biology: multiple roles revealed by analysis of genetically altered mice.

  2009cited by this paper
• Predicting the development of RA in patients with early undifferentiated arthritis.

  2009cited by this paper
• STATs in cancer inflammation and immunity: a leading role for STAT3

  2009cited by this paper
• Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.

  2008cited by this paper
• Oncostatin M Receptor-β Signaling Limits Monocytic Cell Recruitment in Acute Inflammation1

  2008cited by this paper
• Interleukin 27 attenuates collagen-induced arthritis

  2008cited by this paper
• IL-6 Regulates Neutrophil Trafficking during Acute Inflammation via STAT31

  2008cited by this paper
• IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial

  2008cited by this paper
• Ups and downs: the STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling.

  2008cited by this paper
• STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice.

  2008cited by this paper
• Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease.

  2008cited by this paper
• Cutting Edge: Soluble IL-6R Is Produced by IL-6R Ectodomain Shedding in Activated CD4 T Cells1

  2008cited by this paper
• Actemra poised to launch IL-6 inhibitors

  2008cited by this paper
• Cytokines in the pathogenesis of rheumatoid arthritis

  2007influential reference
• Cutting Edge: Trans-Signaling via the Soluble IL-6R Abrogates the Induction of FoxP3 in Naive CD4+CD25− T Cells1

  2007cited by this paper
• The IL-6/sIL-6R complex as a novel target for therapeutic approaches

  2007cited by this paper
• Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10

  2007cited by this paper
• Targeting TACE-dependent EGFR ligand shedding in breast cancer.

  2007cited by this paper
• Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production

  2007cited by this paper
• Interleukin‐6 and its receptor in cancer

  2007cited by this paper
• Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils.

  2007cited by this paper
• Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis.

  2006cited by this paper
• Interleukin 27 negatively regulates the development of interleukin 17–producing T helper cells during chronic inflammation of the central nervous system

  2006cited by this paper
• Interleukin‐6 biology is coordinated by membrane‐bound and soluble receptors: role in inflammation and cancer

  2006cited by this paper
• Understanding the IL-23-IL-17 immune pathway.

  2006cited by this paper
• TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

  2006cited by this paper
• Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis.

  2006cited by this paper
• Functional characterization of a soluble gp130 isoform and its therapeutic capacity in an experimental model of inflammatory arthritis.

  2006cited by this paper
• The Jak-STAT pathway in rheumatoid arthritis.

  2005cited by this paper
• Viral IL-6 Blocks Neutrophil Infiltration during Acute Inflammation1

  2005cited by this paper
• Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease.

  2005cited by this paper
• New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions

  2005cited by this paper
• Directing Transition from Innate to Acquired Immunity: Defining a Role for IL-61

  2005influential reference
• Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-β signaling

  2005cited by this paper
• IL-6 transsignaling: the in vivo consequences.

  2005influential reference
• The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo.

  2005cited by this paper
• Humanized anti-interleukin-6 receptor antibody

  2005cited by this paper
• Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice

  2004cited by this paper
• TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling

  2004cited by this paper
• Differential Regulation of Neutrophil-Activating Chemokines by IL-6 and Its Soluble Receptor Isoforms1

  2004cited by this paper
• TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.

  2004cited by this paper
• WSX-1 and Glycoprotein 130 Constitute a Signal-Transducing Receptor for IL-27

  2004cited by this paper
• Inhibition of T Cell Apoptosis in the Aqueous Humor of Patients with Uveitis by IL-6/Soluble IL-6 Receptor trans-Signaling

  2004cited by this paper
• Local activation of STAT-1 and STAT-3 in the inflamed synovium during zymosan-induced arthritis: exacerbation of joint inflammation in STAT-1 gene-knockout mice.

  2004cited by this paper
• STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: A critical role of STAT3 in innate immunity

  2003influential reference
• Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients

  2003cited by this paper
• Principles of interleukin (IL)-6-type cytokine signalling and its regulation.

  2003influential reference
• Soluble IL-6 Receptor Governs IL-6 Activity in Experimental Arthritis: Blockade of Arthritis Severity by Soluble Glycoprotein 130

  2003cited by this paper
• The JAK/STAT pathway in rheumatoid arthritis: pathogenic or protective?

  2003cited by this paper
• Chemotactic agents induce IL-6Ralpha shedding from polymorphonuclear cells: involvement of a metalloproteinase of the TNF-alpha-converting enzyme (TACE) type.

  2002cited by this paper
• Stat proteins and oncogenesis.

  2002cited by this paper
• Chemotactic agents induce IL‐6Rα shedding from polymorphonuclear cells: involvement of a metalloproteinase of the TNF‐α‐converting enzyme (TACE) type

  2002cited by this paper
• Critical Roles for Interleukin 1 and Tumor Necrosis Factor α in Antibody-induced Arthritis

  2002cited by this paper
• The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases.

  2002cited by this paper
• Minireview: Neuro-immuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling molecules.

  2002cited by this paper
• Development of anti-TNF therapy for rheumatoid arthritis

  2002influential reference
• The soluble interleukin 6 receptor: mechanisms of production and implications in disease

  2001cited by this paper
• Severe inflammatory arthritis and lymphadenopathy in the absence of TNF.

  2001cited by this paper
• Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis

  2001cited by this paper
• The IL-6-Soluble IL-6Rα Autocrine Loop of Endothelial Activation as an Intermediate Between Acute and Chronic Inflammation: an Experimental Model Involving Thrombin

  2001cited by this paper
• Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.

  2001cited by this paper
• Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation.

  2001cited by this paper
• Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo

  2000cited by this paper
• CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex

  2000cited by this paper
• Activation-Induced Inhibition of Interleukin 6–Mediated T Cell Survival and Signal Transducer and Activator of Transcription 1 Signaling

  2000cited by this paper
• IL-6 Receptor Independent Stimulation of Human gp130 by Viral IL-61

  2000cited by this paper
• Roles of STAT3 defined by tissue-specific gene targeting

  2000cited by this paper
• C-reactive Protein: A Physiological Activator of Interleukin 6 Receptor Shedding

  1999cited by this paper
• IL‐6‐deficient mice resist myelin oligodendrocyte glycoprotein‐induced autoimmune encephalomyelitis

  1998cited by this paper
• An anti‐inflammatory role for interleukin‐11 in established murine collagen‐induced arthritis

  1998cited by this paper
• TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination

  1998cited by this paper
• Important immunoregulatory role of interleukin-11 in the inflammatory process in rheumatoid arthritis.

  1998cited by this paper

• Exercise-modulated IL-6 in cancer cachexia: molecular mechanisms and therapeutic potential

  2026cites this paper
• The role of cytokines in cytokine release syndrome (CRS) after CAR T cell therapy.

  2026cites this paper
• Inhibition of inflammation by IL-6 blockade in xenotransplantation.

  2025cites this paper
• N-salicyloyl tryptamine derivative exerts antiatherosclerotic effects by ameliorating endothelial inflammation and apoptosis.

  2025cites this paper
• Sepsis: the evolution of molecular pathogenesis concepts and clinical management

  2025cites this paper
• Role of Interleukin-6 Mediated T Cell Activation in Experimental Acute Pancreatitis

  2025cites this paper
• A Mendelian Randomization Study and Experimental Validation Investigating the Potential Relationship Among Interleukin‐6 Receptor Subunit Beta, Obesity, and Alzheimer's Disease

  2025cites this paper
• Moving Towards the Delivery of Outpatient T-Cell Engaging Therapy for the Management of Multiple Myeloma.

  2025cites this paper
• The effects of sulfate on the physiology, biochemistry, and intestinal transcriptome of Scylla paramamosain under low-salinity conditions.

  2025cites this paper
• Reduced interleukin-6 stress reactivity in male physicians with occupational burnout

  2025cites this paper
• Trans-signaling through the agonistic sIL-6R and an imbalanced inflammatory response are associated with increased susceptibility to Graves' disease.

  2025cites this paper
• Sarcopenic obesity: prospects of mitochondrial transplantation to combat metabolic deterioration in aging

  2025cites this paper
• Cytokine release syndrome in solid tumors

  2025cites this paper
• The Interconnected World of Coagulation Factors, Platelets and Plasminogen: A Novel Perspective on Biosynthetic Regulation

  2025cites this paper
• Disparate Roles of Cell–Cell Contact and Cytokine Secretion in an In Vitro Model of the Seminoma Microenvironment

  2025cites this paper
• Phenotypes in Brugada syndrome with different genotypes triggered by fever or inflammation using gene-edited iPSCs

  2025cites this paper
• Mechanism of interleukin-6 cytokine family in bone metastasis of lung cancer and prospects for its application.

  2025cites this paper
• The adipokines in oral cancer pathogenesis and its potential as a new therapeutic approach

  2025cites this paper
• Gut microbiome-adipose crosstalk modulates soluble IL-6 receptor influencing exercise responsiveness in glycemic control and insulin sensitivity.

  2025cites this paper
• Homoharringtonine: mechanisms, clinical applications and research progress

  2025cites this paper
• Bazedoxifene as a Potential Cancer Therapeutic Agent Targeting IL-6/GP130 Signaling

  2024cites this paper
• HSCs-derived exosomes regulate the levels of inflammatory cytokines in HIBECs through miR-122-5p mediated p38 MAPK signaling pathway.

  2024cites this paper
• Spatiotemporal Clusters of Extracellular Signal-Regulated Kinase Activity Coordinate Cytokine-induced Inflammatory Responses in Human Airway Epithelial Cells

  2024cites this paper
• Exerkines and cardiometabolic benefits of exercise: from bench to clinic

  2024cites this paper
• Spatiotemporal Clusters of ERK Activity Coordinate Cytokine-induced Inflammatory Responses in Human Airway Epithelial Cells

  2024cites this paper
• New insights into protein–protein interaction modulators in drug discovery and therapeutic advance

  2024cites this paper
• Research Advances in Fusion Protein-Based Drugs for Diabetes Treatment

  2024cites this paper
• Identification of urine biomarkers of endometriosis—Protein mass spectrometry

  2024cites this paper
• Usefulness of neutrophil-to-lymphocyte count ratio, procalcitonin, and interleukin-6 for severity assessment of bacterial sepsis

  2024cites this paper
• IL-1 and TNF mediates IL-6 signaling at the maternal-fetal interface during intrauterine inflammation

  2024cites this paper
• Graft‐versus‐leukaemia immunity is retained following treatment with post‐transplant cyclophosphamide alone or combined with tocilizumab in humanised mice

  2024cites this paper
• Cardiotrophin‐1 therapy reduces disease severity in a murine model of glomerular disease

  2024cites this paper
• Pharmacologic inhibition of Il6st/gp130 improves dermatological inflammation and pruritus.

  2024cites this paper
• Bisphenol A and selenium deficiency exposure induces pyroptosis and myogenic differentiation disorder in chicken muscle stomach

  2024cites this paper
• Prognostic Significance of Plasma Soluble IL-6 Receptor in Carbon-ion Radiotherapy for Pancreatic Cancer

  2024cites this paper
• Targeting IL-6 trans-signalling: past, present and future prospects

  2023cites this paper
• The RNA editor ADAR2 promotes immune cell trafficking by enhancing endothelial responses to interleukin-6 during sterile inflammation.

  2023cites this paper
• Post-hepatectomy liver failure: A timeline centered review.

  2023cites this paper
• Anti-inflammatory role of extracellular l-arginine through calcium sensing receptor in human renal proximal tubular epithelial (HK-2) cells.

  2023cites this paper
• Perspective for Discovery of Small Molecule IL-6 Inhibitors through Study of Structure-Activity Relationships and Molecular Docking.

  2023cites this paper
• Tocilizumab increases regulatory T cells, reduces natural killer cells and delays graft‐versus‐host disease development in humanized mice treated with post‐transplant cyclophosphamide

  2023cites this paper
• Th1 Cells Alter the Inflammatory Signature of IL-6 by Channeling STAT Transcription Factors to Alu-like Retroelements

  2023cites this paper
• Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events

  2023cites this paper
• Cellular Senescence: From Mechanisms to Current Biomarkers and Senotherapies

  2023cites this paper
• Recent Progresses in Optical Biosensors for Interleukin 6 Detection

  2023influential citation
• Potential value of Interleukin-6 as a diagnostic biomarker in human MDD and the antidepressant effect of its receptor antagonist tocilizumab in lipopolysaccharide-challenged rats.

  2023cites this paper
• Bacterial Lipoteichoic Acid Induces Capsular Contracture by Activating Innate Immune Response

  2023cites this paper
• Development and Validation of Potential Molecular Subtypes and Signatures of Thyroid Carcinoma Based on Aging-related Gene Analysis

  2023cites this paper
• Predicting Tumour Progression of ID-8 Syngeneic Mouse Ovarian Cancer with Blood Biomarkers of CA-125, IL-6 and VEGF: A Prospective Laboratory-Based Study

  2023cites this paper
• Role of interleukin 6 and its soluble receptor on the diffusion barrier dysfunction of alveolar tissue

  2023cites this paper
• Th1 Cells Alter the In fl ammatory Signature of IL-6 by Channeling STAT Transcription Factors to Alu -like Retroelements

  2023cites this paper
• Modulation of Pro-Inflammatory IL-6 Trans-Signaling Axis by Splice Switching Oligonucleotides as a Therapeutic Modality in Inflammation

  2023cites this paper
• Dissecting Interleukin-6 Classic and Trans-signaling in Inflammation and Cancer.

  2023cites this paper
• Exploring the landscape of synthetic IL‐6‐type cytokines

  2023cites this paper
• The gp130/STAT3-endoplasmic reticulum stress axis regulates hepatocyte necroptosis in acute liver injury

  2023cites this paper
• Co-Targeting IL-6 and EGFR signaling for the treatment of schwannomatosis and associated pain

  2023cites this paper
• The Physiological and Pathophysiological Role of IL-6/STAT3-Mediated Signal Transduction and STAT3 Binding Partners in Therapeutic Applications.

  2023cites this paper
• Rational Design of Molecular Phototheranostic Platform for NIR-II fluorescence Imaging Guided Chemodynamic-Photothermal Combined Therapy

  2023cites this paper
• Research Progress of Interleukin-27 in Inflammatory Bowel Disease.

  2023cites this paper
• New Trends in the Impact of Periodontal Treatment on Early Cardiovascular Diseases Outcomes: Insights and Future Perspectives

  2023cites this paper
• Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic Implications

  2023cites this paper
• RasGRP1 promotes the acute inflammatory response and restricts inflammation-associated cancer cell growth

  2022cites this paper
• Quercitrin neutralizes sPLA2IIa activity, reduces the inflammatory IL-6 level in PC3 cell lines, and exhibits anti-tumor activity in the EAC-bearing mice model

  2022cites this paper
• Performance, Feeding Behavior and Immune Response in Nellore and Angus × Nellore Steers Fed Whole Shelled Corn Diets with or without Fiber

  2022cites this paper
• Interleukin-6 and indoleamine-2,3-dioxygenase as potential adjuvant targets for Papillomavirus-related tumors immunotherapy

  2022cites this paper
• Self‐Assembly of Immune Signals to Program Innate Immunity through Rational Adjuvant Design

  2022cites this paper
• A Vicious Cycle: In Severe and Critically Ill COVID-19 Patients

  2022cites this paper
• Autoimmunity, cancer and COVID-19 abnormally activate wound healing pathways: critical role of inflammation

  2022cites this paper
• Hypocomplementemia during tocilizumab treatment

  2022cites this paper
• Up-Conversion Luminescence System for Quantitative Detection of IL-6

  2022cites this paper
• Severe acute respiratory syndrome coronavirus 2 infection: Role of interleukin-6 and the inflammatory cascade

  2022cites this paper
• The Role of Inflammatory Mediators in Colorectal Cancer Hepatic Metastasis

  2022cites this paper
• (Dis)similarities between the Decidual and Tumor Microenvironment

  2022cites this paper
• Co-Occurrence of Interleukin-6 Receptor Asp358Ala Variant and High Plasma Levels of IL-6: An Evidence of IL-6 Trans-Signaling Activation in Deep Vein Thrombosis (DVT) Patients

  2022cites this paper
• The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy

  2022cites this paper
• β-Klotho promotes glycolysis and glucose-stimulated insulin secretion via GP130

  2022cites this paper
• Blockade of mIL‐6R alleviated lipopolysaccharide‐induced systemic inflammatory response syndrome by suppressing NF‐κB‐mediated Ccl2 expression and inflammasome activation

  2022cites this paper
• Targeted therapy in Coronavirus disease 2019 (COVID-19): Implication from cell and gene therapy to immunotherapy and vaccine

  2022cites this paper
• The role of Janus kinases in the pathogenesis and treatment of covid-19

  2022cites this paper
• Lessons From the Success and Failure of Targeted Drugs for Rheumatoid Arthritis: Perspectives for Effective Basic and Translational Research

  2022cites this paper
• Cell Type-Specific Roles of STAT3 Signaling in the Pathogenesis and Progression of K-ras Mutant Lung Adenocarcinoma

  2022influential citation
• Anti‐inflammatory actions of acetate, propionate, and butyrate in fetal mouse jejunum cultures ex vivo and immature small intestinal cells in vitro

  2022cites this paper
• Discovery and characterization of a monoclonal antibody targeting a conformational epitope of IL-6/IL-6Rα to inhibit IL-6/ IL-6Rα/gp130 hexameric signaling complex formation

  2022cites this paper
• IL-6 Signaling Link between Inflammatory Tumor Microenvironment and Prostatic Tumorigenesis

  2022cites this paper
• A New Approach to the Management of COVID-19. Antagonists of IL-6: Siltuximab

  2022cites this paper
• CRLF1 and CLCF1 in Development, Health and Disease

  2022cites this paper
• Soluble forms of cytokine and growth factor receptors: mechanisms of generation and modes of action in the regulation of local and systemic inflammation

  2022cites this paper
• Interleukin 35 contributes to immunosuppression by regulating inflammatory cytokines and T cell populations in the acute phase of sepsis.

  2022cites this paper
• Modulation of interleukin-6 and its effect on late vein wall injury in a stasis mouse model of deep vein thrombosis

  2022cites this paper
• IL-6/STAT3 Signaling Promotes Cardiac Dysfunction by Upregulating FUNDC1-Dependent Mitochondria-Associated Endoplasmic Reticulum Membranes Formation in Sepsis Mice

  2022cites this paper
• Adipokines from white adipose tissue in regulation of whole body energy homeostasis.

  2022cites this paper
• Hyperbaric oxygen treatment is associated with a decrease in cytokine levels in patients with necrotizing soft‐tissue infection

  2021cites this paper
• Association of Adipose Tissue and Adipokines with Development of Obesity-Induced Liver Cancer

  2021cites this paper
• Ras guanine nucleotide exchange factor RasGRP1 promotes acute inflammatory response and restricts inflammation-contributed cancer cell growth

  2021cites this paper
• IL-6 can singlehandedly drive many features of frailty in mice

  2021cites this paper
• Local and systemic effects of interleukin‐6 (IL‐6) in inflammation and cancer

  2021cites this paper
• Alterations in cortisol and interleukin-6 secretion in patients with COVID-19 suggestive of neuroendocrine-immune adaptations

  2021cites this paper
• Brain-Restricted Inhibition of IL-6 Trans-Signaling Mildly Affects Metabolic Consequences of Maternal Obesity in Male Offspring

  2021cites this paper
• Targets of Vitamin C With Therapeutic Potential for Cardiovascular Disease and Underlying Mechanisms: A Study of Network Pharmacology

  2021cites this paper
• A case of effective use of interleukin 6 inhibitors in patients with ankylosing spondylitis with secondary amyloidosis

  2021cites this paper